Benefits of MINOCA Stratified Treatment
Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) often experience persistent symptoms. However, a recent study shows that MINOCA stratified treatment significantly improves angina status at one year. This approach identifies specific underlying causes, such as coronary spasm or plaque rupture. Consequently, clinicians can tailor therapy to each patient’s unique pathophysiology. This precision strategy outperforms the standard of care which often relies on generic heart attack protocols.
Personalized Diagnosis and Better Outcomes
The PROMISE trial demonstrated that cause-guided therapy leads to superior symptom control. Specifically, researchers used advanced imaging and invasive tests to reclassify diagnoses in over 75% of cases. Therefore, patients received more accurate treatments, such as nitrates for vasospasm or statins for plaque erosion. In addition, this targeted approach reduced the Seattle Angina Questionnaire scores significantly compared to standard care. Furthermore, the stratified group reported better quality of life and fewer recurrent chest pain episodes.
Transitioning to a stratified model requires advanced diagnostic tools like cardiac MRI and optical coherence tomography. Although these tests require more resources, they prevent ineffective long-term medication use. Therefore, implementing this protocol could optimize recovery for MINOCA patients. Doctors should consider these findings to refine their management strategies for non-obstructive coronary events.
Frequently Asked Questions
Q1: What is the primary benefit of MINOCA stratified treatment?
It provides significant improvement in angina status and quality of life by tailoring therapies to the specific cause of the heart attack.
Q2: How does the stratified approach differ from standard care?
Standard care uses a generic protocol for heart attacks, while stratified treatment uses advanced imaging to identify and treat the exact cause.
References
- Romiti GF et al. In MINOCA, stratified treatment guided by MINOCA cause vs. standard care improved angina status at 1 y. Ann Intern Med. 2026 Apr 07. doi: 10.7326/ANNALS-26-00758-JC. PMID: 41941740.
- Montone RA, et al. Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial. Eur Heart J. 2025.
- Tamis-Holland JE, et al. Contemporary Diagnosis and Management of Patients With MINOCA. Circulation. 2019.